Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerome Rollin

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Blood Advances|March 18, 2025
Cooperative effect between anti-PF4/H and anti-PF4 antibodies increases cell activation and thrombotic risk in HITSandra Billy, Caroline Vayne, Ophélie Bertin, et al.
Blood Advances|May 17, 2023
Treatment of thrombocytopenia and thrombosis in HIT in mice using deglycosylated KKO: a novel therapeutic?Amrita Sarkar, Sanjay Khandelwal, Gavin T Koma, et al.
Journal of Thrombosis and Haemostasis : JTH|January 25, 2023
Modulation of ultralarge immune complexes in heparin-induced thrombocytopeniaZheng Cai, Khalil Bdeir, Serge V Yarovoi, et al.
Thrombosis Research|August 4, 2023
Laboratory and demographic predictors of functional assay positive status in suspected heparin-induced thrombocytopenia: A multicenter retrospective cohort studyJason B Giles, Jerome Rollin, Kiana L Martinez, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Antiphospholipid syndrome (APS) is a platelet factor 4 (PF4)-centric immunothrombotic disorderConroy O Field, Amrita Sarkar, Khalil Bdeir, et al.
Thrombosis and Haemostasis|December 16, 2014
A genome-wide association study of heparin-induced thrombocytopenia using an electronic medical recordJason H Karnes, Robert M Cronin, Jerome Rollin, et al.
Blood Advances|May 9, 2022
Genome-wide association study of platelet factor 4/heparin antibodies in heparin-induced thrombocytopeniaJason B Giles, Heidi E Steiner, Jerome Rollin, et al.
Blood|April 4, 2022
ABO O blood group as a risk factor for platelet reactivity in heparin-induced thrombocytopeniaJason H Karnes, Jerome Rollin, Jason B Giles, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Blood Advances|March 18, 2025
Cooperative effect between anti-PF4/H and anti-PF4 antibodies increases cell activation and thrombotic risk in HITSandra Billy, Caroline Vayne, Ophélie Bertin, et al.
Blood Advances|May 17, 2023
Treatment of thrombocytopenia and thrombosis in HIT in mice using deglycosylated KKO: a novel therapeutic?Amrita Sarkar, Sanjay Khandelwal, Gavin T Koma, et al.
Journal of Thrombosis and Haemostasis : JTH|January 25, 2023
Modulation of ultralarge immune complexes in heparin-induced thrombocytopeniaZheng Cai, Khalil Bdeir, Serge V Yarovoi, et al.
Thrombosis Research|August 4, 2023
Laboratory and demographic predictors of functional assay positive status in suspected heparin-induced thrombocytopenia: A multicenter retrospective cohort studyJason B Giles, Jerome Rollin, Kiana L Martinez, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Antiphospholipid syndrome (APS) is a platelet factor 4 (PF4)-centric immunothrombotic disorderConroy O Field, Amrita Sarkar, Khalil Bdeir, et al.
Thrombosis and Haemostasis|December 16, 2014
A genome-wide association study of heparin-induced thrombocytopenia using an electronic medical recordJason H Karnes, Robert M Cronin, Jerome Rollin, et al.
Blood Advances|May 9, 2022
Genome-wide association study of platelet factor 4/heparin antibodies in heparin-induced thrombocytopeniaJason B Giles, Heidi E Steiner, Jerome Rollin, et al.
Blood|April 4, 2022
ABO O blood group as a risk factor for platelet reactivity in heparin-induced thrombocytopeniaJason H Karnes, Jerome Rollin, Jason B Giles, et al.
Pageof 1